| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Anjana Bali | Q84904833 |
| P2093 | author name string | Amteshwar Singh Jaggi | |
| Nirmal Singh | |||
| Varun Parkash Singh | |||
| P2860 | cites work | RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides | Q22010236 |
| Diabetes Treatment — Bridging the Divide | Q22250871 | ||
| Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro | Q22253281 | ||
| Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis | Q22254188 | ||
| Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins | Q24292994 | ||
| Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes | Q24627259 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Therapeutic potential of breakers of advanced glycation end product–protein crosslinks | Q28211259 | ||
| The immunoglobulin fold. Structural classification, sequence patterns and common core | Q28239187 | ||
| Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs | Q28290998 | ||
| Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites | Q28304259 | ||
| Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice | Q28344139 | ||
| Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE) | Q28366662 | ||
| Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells | Q28570142 | ||
| Skin aging by glycation: lessons from the reconstructed skin model. | Q50904697 | ||
| Müller glial dysfunction during diabetic retinopathy in rats is linked to accumulation of advanced glycation end-products and advanced lipoxidation end-products. | Q53286585 | ||
| Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. | Q53530417 | ||
| Receptor for advanced glycation end products is a promising target of diabetic nephropathy. | Q53850227 | ||
| Glycated collagen alters endothelial cell actin alignment and nitric oxide release in response to fluid shear stress. | Q54591364 | ||
| The Immunoglobulin Fold | Q55932791 | ||
| Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy | Q57920423 | ||
| Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases | Q59084980 | ||
| Site-specific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species | Q67860000 | ||
| Glycation alters collagen fibril organization | Q68202935 | ||
| Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients | Q69466636 | ||
| NA+/K+ ATPase impairment and experimental glycation: the role of glucose autoxidation | Q71331732 | ||
| PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products | Q71754502 | ||
| Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats | Q71800567 | ||
| Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats | Q71909295 | ||
| Glycation of monoclonal antibodies impairs their ability to bind antigen | Q72792607 | ||
| Administration of AGEs in vivo induces extracellular matrix gene expression | Q73097848 | ||
| Glycation--a sweet tempter for neuronal death | Q73187566 | ||
| Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus | Q73406158 | ||
| Strain differences in susceptibility to streptozotocin-induced diabetes: effects on hypertriglyceridemia and cardiomyopathy | Q73499526 | ||
| Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia | Q38292287 | ||
| Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. | Q38309468 | ||
| Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes | Q38317661 | ||
| Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta | Q38524676 | ||
| Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation. | Q38700889 | ||
| Impact of carbamylation and glycation of collagen type I on migration of HT1080 human fibrosarcoma cells | Q39387928 | ||
| Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group | Q39481123 | ||
| Diabetic cardiomyopathy: how much does it depend on AGE? | Q39572876 | ||
| Hyperglycaemia-induced pro-inflammatory responses by retinal Müller glia are regulated by the receptor for advanced glycation end-products (RAGE). | Q39656639 | ||
| Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). | Q39955806 | ||
| Genotoxicity of advanced glycation end products in mammalian cells | Q40673270 | ||
| Improved arterial compliance by a novel advanced glycation end-product crosslink breaker | Q40684856 | ||
| Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy | Q40700661 | ||
| Energy metabolism of the heart: from basic concepts to clinical applications | Q40748839 | ||
| Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex | Q28577438 | ||
| N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression | Q28645594 | ||
| Nonenzymatic glycation alters protein structure and stability. A study of two eye lens crystallins | Q30422082 | ||
| Role of glycation in human lens protein structure change. | Q30425259 | ||
| Differential accumulation of advanced glycation end products in the course of diabetic retinopathy | Q30724348 | ||
| Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase | Q30749317 | ||
| Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG. | Q30841683 | ||
| Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy | Q33691265 | ||
| Experimental diabetic neuropathy: an update | Q33706830 | ||
| Comparison of modification sites formed on human serum albumin at various stages of glycation | Q33733746 | ||
| Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications | Q34049428 | ||
| Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes | Q34180296 | ||
| Mechanisms of diabetic vasculopathy: an overview. | Q34258094 | ||
| Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. | Q34280300 | ||
| Advanced protein glycosylation in diabetes and aging | Q34298835 | ||
| The maillard reaction in eye diseases | Q34436018 | ||
| Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy | Q34446860 | ||
| The Maillard hypothesis on aging: time to focus on DNA. | Q34614549 | ||
| Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery? | Q34625742 | ||
| Curcumin ameliorates hepatic fibrosis in type 2 diabetes mellitus - insights into its mechanisms of action | Q34636977 | ||
| Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes | Q34662319 | ||
| Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. | Q34728855 | ||
| Advanced glycation end products and insulin resistance | Q34778119 | ||
| Review article: albumin as a drug--biological effects of albumin unrelated to oncotic pressure | Q34992524 | ||
| The role of advanced glycation in the pathogenesis of diabetic retinopathy. | Q35166467 | ||
| Role of advanced glycation end products in diabetic nephropathy. | Q35182368 | ||
| Advanced glycation end products in diabetic and non-diabetic human subjects suffering from cataract | Q35201120 | ||
| Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus | Q35469486 | ||
| Recent advances in diabetic nephropathy | Q35520625 | ||
| Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders | Q35563889 | ||
| Regulator of Calcineurin 1 Isoform 4 (RCAN1.4) Is Overexpressed in the Glomeruli of Diabetic Mice | Q35569376 | ||
| Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins | Q35748423 | ||
| Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype | Q35764301 | ||
| Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus | Q73793973 | ||
| Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility | Q73831601 | ||
| High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner | Q74065752 | ||
| Localization in human diabetic peripheral nerve of N(epsilon)-carboxymethyllysine-protein adducts, an advanced glycation endproduct | Q74110788 | ||
| Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease | Q74246043 | ||
| Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products | Q74450189 | ||
| Diabetic retinopathy | Q75217418 | ||
| CD36, serves as a receptor for advanced glycation endproducts (AGE) | Q77712197 | ||
| Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells | Q77795098 | ||
| Role of oxidative stress in diabetic complications: a new perspective on an old paradigm | Q77804864 | ||
| Advanced glycation endproduct-induced calcium handling impairment in mouse cardiac myocytes | Q78409002 | ||
| Diabetic cardiomyopathy | Q79091215 | ||
| Kinetic analysis on the sensitivity of glucose- or glyoxal-induced LDL glycation to the inhibitory effect of Psidium guajava extract in a physiomimic system | Q79809168 | ||
| Protection against methylglyoxal-derived AGEs by regulation of glyoxalase 1 prevents retinal neuroglial and vasodegenerative pathology | Q82814955 | ||
| Physicochemical studies on glycation-induced structural changes in human IgG | Q83224671 | ||
| Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level | Q83565130 | ||
| Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats | Q83979831 | ||
| Effects of trace elements on albumin and lipoprotein glycation in diabetic retinopathy | Q84743334 | ||
| Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression | Q85472624 | ||
| Regulation of connective tissue growth factor activity in cultured rat mesangial cells and its expression in experimental diabetic glomerulosclerosis | Q95811801 | ||
| Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes? | Q40802125 | ||
| The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells | Q40877248 | ||
| Korean red ginseng extract alleviates advanced glycation end product-mediated renal injury | Q40879985 | ||
| Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix | Q41083561 | ||
| Studies of the permeation properties of glomerular basement membrane: cross-linking renders glomerular basement membrane permeable to protein | Q41113788 | ||
| Receptor-Mediated Toxicity to Pericytes of Advanced Glycosylation End Products: A Possible Mechanism of Pericyte Loss in Diabetic Microangiopathy | Q41311207 | ||
| Structure of advanced Maillard reaction products and their pathological role | Q41357626 | ||
| Effect of dicarbonyl-induced browning on alpha-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays | Q41764565 | ||
| Diabetic cataract-pathogenesis, epidemiology and treatment. | Q41776952 | ||
| Conformational changes induced in lens alpha- and gamma-crystallins by modification with glucose 6-phosphate. Implications for cataract | Q41975540 | ||
| The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment | Q42037633 | ||
| Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose | Q42070713 | ||
| Nonenzymatically glycated albumin (Amadori adducts) enhances nitric oxide synthase activity and gene expression in endothelial cells | Q42528768 | ||
| Advanced glycation end products attenuate cellular insulin sensitivity by increasing the generation of intracellular reactive oxygen species in adipocytes | Q42833739 | ||
| Methylglyoxal-modified collagen promotes myofibroblast differentiation. | Q43083916 | ||
| Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth fac | Q43245112 | ||
| Effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy in patients with type 2 diabetes, in relation to suppression of N(ɛ)-carboxymethyl lysine | Q43283883 | ||
| Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy | Q43741352 | ||
| Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes | Q43858816 | ||
| Telmisartan inhibits AGE-induced podocyte damage and detachment | Q43923673 | ||
| Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy | Q43935483 | ||
| Glucose, glycotoxins, and protein glycation products: the role in pathogensis | Q44019741 | ||
| Age-related changes in the collagen network and toughness of bone | Q44058103 | ||
| Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain | Q44198123 | ||
| Renal connective tissue growth factor induction in experimental diabetes is prevented by aminoguanidine | Q44226053 | ||
| RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. | Q44228474 | ||
| Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes | Q44244855 | ||
| Increased levels of advanced glycation end products in human cataractous lenses | Q44461896 | ||
| Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion | Q44518765 | ||
| Glycolaldehyde induces cytotoxicity and increases glutathione and multidrug-resistance-associated protein levels in Schwann cells | Q44526079 | ||
| Increased concentration of pentosidine, an advanced glycation end product, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy | Q44570636 | ||
| The Role of Advanced Glycation End Products in Retinal Microvascular Leukostasis | Q44595283 | ||
| Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants. | Q44799753 | ||
| Pentosidine effects on human osteoblasts in vitro. | Q44843167 | ||
| Hesperidin prevents retinal and plasma abnormalities in streptozotocin-induced diabetic rats. | Q44897378 | ||
| Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells | Q44944959 | ||
| Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. | Q44953934 | ||
| Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans | Q44998621 | ||
| Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. | Q45122703 | ||
| Ameliorative potential of spironolactone in diabetes induced hyperalgesia in mice. | Q46022826 | ||
| Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress. | Q46295739 | ||
| Levels of soluble advanced glycation end product-receptors and other soluble serum markers as indicators of diabetic neuropathy in the foot | Q46312819 | ||
| Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats | Q46363480 | ||
| Could oxidative stress associate with age products in cataractogenesis? | Q46433995 | ||
| Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus | Q46991176 | ||
| High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappaB activation and cytokine expression | Q47261569 | ||
| Pyridoxamine, an inhibitor of protein glycation, in relation to microalbuminuria and proinflammatory cytokines in experimental diabetic nephropathy | Q47718934 | ||
| Glycated albumin modulates platelet susceptibility to flow induced activation and aggregation | Q47815144 | ||
| Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation | Q35840913 | ||
| Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. | Q35878806 | ||
| Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy | Q35896615 | ||
| The clinical relevance of advanced glycation endproducts (AGE) and recent developments in pharmaceutics to reduce AGE accumulation | Q35950021 | ||
| New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology | Q35988000 | ||
| Advanced glycation endproducts--role in pathology of diabetic complications | Q35994161 | ||
| Importance of measuring products of non-enzymatic glycation of proteins | Q36005178 | ||
| Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury | Q36063080 | ||
| The renin-angiotensin-aldosterone system, glucose metabolism and diabetes | Q36088736 | ||
| Role of advanced glycation end products and their receptors in development of diabetic neuropathy | Q36203976 | ||
| Advanced glycation end products and the kidney | Q36256248 | ||
| Diabetes and the kidney | Q36267504 | ||
| Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus | Q36318505 | ||
| Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. | Q36438245 | ||
| Role of N-ε- carboxy methyl lysine, advanced glycation end products and reactive oxygen species for the development of nonproliferative and proliferative retinopathy in type 2 diabetes mellitus. | Q36574142 | ||
| The effects of the Maillard reaction on the physical properties and cell interactions of collagen | Q36589605 | ||
| Advanced glycation end-products stimulate basic fibroblast growth factor expression in cultured Müller cells | Q36610702 | ||
| Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies | Q36776930 | ||
| The Extract of Litsea japonica Reduced the Development of Diabetic Nephropathy via the Inhibition of Advanced Glycation End Products Accumulation in db/db Mice | Q36918392 | ||
| A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease | Q37097143 | ||
| Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. | Q37308593 | ||
| The wanderings of a free radical | Q37359179 | ||
| Hyperglycemia and glycation in diabetic complications. | Q37505050 | ||
| Role of oxidative stress in development of complications in diabetes | Q37681089 | ||
| Therapeutic strategies for diabetic neuropathy | Q37738319 | ||
| The pathogenic role of Maillard reaction in the aging eye. | Q37801857 | ||
| The glycation of albumin: structural and functional impacts | Q37822078 | ||
| AGEs, RAGE, and diabetic retinopathy | Q37876790 | ||
| Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease | Q38017227 | ||
| The renin-angiotensin system and advanced glycation end-products in diabetic retinopathy: impacts and synergies | Q38061703 | ||
| Diabetes-related adduct formation and retinopathy. | Q38070160 | ||
| Advanced glycation end products: role in pathology of diabetic cardiomyopathy | Q38081119 | ||
| Microorganisms and Maillard reaction products: a review of the literature and recent findings. | Q38099209 | ||
| Advanced glycation end products and diabetic retinopathy. | Q38112709 | ||
| AGEs, rather than hyperglycemia, are responsible for microvascular complications in diabetes: a "glycoxidation-centric" point of view | Q38115856 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 1-14 | |
| P577 | publication date | 2014-02-13 | |
| P1433 | published in | Korean Journal of Physiology and Pharmacology | Q15757587 |
| P1476 | title | Advanced glycation end products and diabetic complications | |
| P478 | volume | 18 |
| Q92703724 | 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-oxodG) and 8-Hydroxy-2'-Deoxyguanosine (8-OHdG) as a Potential Biomarker for Gestational Diabetes Mellitus (GDM) Development |
| Q44475765 | A Caenorhabditis elegans Model Elucidates a Conserved Role for TRPA1-Nrf Signaling in Reactive α-Dicarbonyl Detoxification |
| Q53597491 | A Combination of Intravenous Genistein Plus Mg2+ Enhances Antihypertensive Effects in SHR by Endothelial Protection and BKCa Channel Inhibition. |
| Q59809890 | A Network Pharmacology Approach to Uncover the Mechanisms of Shen-Qi-Di-Huang Decoction against Diabetic Nephropathy |
| Q57169810 | A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4 |
| Q96303470 | A Synoptic Overview of Neurovascular Interactions in the Foot |
| Q55361805 | AGE/RAGE-Induced EMP Release via the NOX-Derived ROS Pathway. |
| Q91658186 | Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study |
| Q53244774 | Activation of Macrophages and Microglia by Interferon-γ and Lipopolysaccharide Increases Methylglyoxal Production: A New Mechanism in the Development of Vascular Complications and Cognitive Decline in Type 2 Diabetes Mellitus? |
| Q38813166 | Activation of α7nAChR Promotes Diabetic Wound Healing by Suppressing AGE-Induced TNF-α Production |
| Q90494387 | Acupuncture as adjuvant therapy for diabetic foot: A protocol for systematic review |
| Q92184840 | Adipose Tissue Protein Glycoxidation is Associated with Weight-Loss Potential |
| Q64929070 | Adipose-derived Stem Cells Attenuates Diabetic Osteoarthritis via Inhibition of Glycation-mediated Inflammatory Cascade. |
| Q57115778 | Advanced Glycation End Products Increase MDM2 Expression via Transcription Factor KLF5 |
| Q93023394 | Advanced Glycation End-Products Suppress Mitochondrial Function and Proliferative Capacity of Achilles Tendon-Derived Fibroblasts |
| Q47197460 | Advanced glycation end products as a source of artifacts in immunoenzymatic methods. |
| Q41836455 | Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial |
| Q33730962 | Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function. |
| Q33596312 | Advanced glycation end products in idiopathic frozen shoulders |
| Q55070117 | Advanced glycation end products upregulate the endoplasmic reticulum stress in human periodontal ligament cells. |
| Q36842527 | Advanced glycation endproducts and their receptor in different body compartments in COPD |
| Q49210690 | Age-related oxidative changes in pancreatic islets are predominantly located in the vascular system. |
| Q38788160 | Alcohol Toxicity in Diabetes and Its Complications: A Double Trouble? |
| Q51188702 | All-Trans Retinoic Acid supplementation prevents cardiac fibrosis and cytokines induced by Methylglyoxal. |
| Q92346511 | Almond-supplemented diet improves sexual functions beyond Phosphodiesterase-5 inhibition in diabetic male rats |
| Q52373049 | Alpha-Synuclein Glycation and the Action of Anti-Diabetic Agents in Parkinson's Disease. |
| Q58738843 | Ameliorates Diabetes-Induced Renal Damage by Suppressing Advanced Glycation End Products in db/db Mice |
| Q58707496 | An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells |
| Q35666536 | An estimation of the prevalence of diabetes mellitus and diabetic retinopathy in adults in Timor-Leste. |
| Q34168107 | An overview of the identification and management of the metabolic syndrome in chiropractic practice |
| Q68688700 | Analysis of Chemically Labile Glycation Adducts in Seed Proteins: Case Study of Methylglyoxal-Derived Hydroimidazolone 1 (MG-H1) |
| Q36600193 | Analysis of advanced glycation end products in the DHS Mind Study |
| Q35657285 | Analysis of glycation induced protein cross-linking inhibitory effects of some antidiabetic plants and spices |
| Q40973503 | Anti-Advanced Glycation End-product and Free Radical Scavenging Activity of Plants from the Yucatecan Flora |
| Q90294050 | Anti-glycation, Carbonyl Trapping and Anti-inflammatory Activities of Chrysin Derivatives |
| Q41688529 | Antiamylase, Anticholinesterases, Antiglycation, and Glycation Reversing Potential of Bark and Leaf of Ceylon Cinnamon (Cinnamomum zeylanicum Blume) In Vitro |
| Q94596365 | Antidiabetic Potential of Marine Brown Algae-a Mini Review |
| Q64940239 | Antiglycation and antioxidant activity of four Iranian medical plant extracts. |
| Q47408853 | Antioxidant, Antiglycation, and Hypoglycaemic Effect of Seriphium plumosum Crude Plant Extracts. |
| Q55261079 | Antioxidant, antihyperglycemic, and antidiabetic activity of Apis mellifera bee tea. |
| Q39324415 | Assessment of the Anti-Hyperglycaemic, Anti-Inflammatory and Antioxidant Activities of the Methanol Extract of Moringa Oleifera in Diabetes-Induced Nephrotoxic Male Wistar Rats. |
| Q51245799 | Association between Age and Changes in Heart Rate Variability after Hemodialysis in Patients with Diabetes. |
| Q38364408 | Association between the RAGE gene -374T/A, -429T/C polymorphisms and diabetic nephropathy: a meta-analysis |
| Q50117388 | Attenuation of Glucose-Induced Myoglobin Glycation and the Formation of Advanced Glycation End Products (AGEs) by (R)-α-Lipoic Acid In Vitro |
| Q92438095 | Attenuation of diabetic kidney injury in DPP4-deficient rats; role of GLP-1 on the suppression of AGE formation by inducing glyoxalase 1 |
| Q28073173 | Better Living through Chemistry: Caloric Restriction (CR) and CR Mimetics Alter Genome Function to Promote Increased Health and Lifespan |
| Q39117792 | Biomarkers of oxidative stress in pregnancy complications. |
| Q92328576 | Biosynthesized ZnO-NPs from Morus indica Attenuates Methylglyoxal-Induced Protein Glycation and RBC Damage: In-Vitro, In-Vivo and Molecular Docking Study |
| Q29994589 | Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential |
| Q38829652 | Calycosin Rebalances Advanced Glycation End Products-Induced Glucose Uptake Dysfunction of Hepatocyte In Vitro |
| Q89612411 | Challenges of neuropathic pain: focus on diabetic neuropathy |
| Q41062586 | Classification of skin phenotypes caused by diabetes mellitus using complex scattering parameters in the millimeter-wave frequency range. |
| Q46282077 | Comparative suppressing effects of black and green teas on the formation of advanced glycation end products (AGEs) and AGE-induced oxidative stress |
| Q52647791 | Conflicting Effects of Methylglyoxal and Potential Significance of miRNAs for Seizure Treatment. |
| Q36026951 | Cyanidin-3-rutinoside attenuates methylglyoxal-induced protein glycation and DNA damage via carbonyl trapping ability and scavenging reactive oxygen species |
| Q91840038 | Demographic and Clinical Factors Associated with Development of Type 2 Diabetes: A Review of the Literature |
| Q50957283 | Detection of RAGE expression and its application to diabetic wound age estimation. |
| Q38901757 | Diabetes mellitus and the skin. |
| Q38919955 | Diabetes-induced mechanophysiological changes in the esophagus. |
| Q39427195 | Diabetes-induced mechanophysiological changes in the small intestine and colon |
| Q92733581 | Diabetic neuropathy |
| Q91762128 | Diabetic neuropathy research: from mouse models to targets for treatment |
| Q39451009 | Diabetic retinopathy: Breaking the barrier |
| Q57794821 | Diabetics show accelerated progression of knee cartilage and meniscal lesions: data from the osteoarthritis initiative |
| Q92344331 | Dietary Glycotoxins, Advanced Glycation End Products, Inhibit Cell Proliferation and Progesterone Secretion in Ovarian Granulosa Cells and Mimic PCOS-like Symptoms |
| Q49913426 | Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase. |
| Q54949436 | Diphlorethohydroxycarmalol Attenuates Methylglyoxal-Induced Oxidative Stress and Advanced Glycation End Product Formation in Human Kidney Cells. |
| Q45946065 | Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease. |
| Q47146659 | Downregulation of Profilin-1 Expression Attenuates Cardiomyocytes Hypertrophy and Apoptosis Induced by Advanced Glycation End Products in H9c2 Cells. |
| Q90217768 | Effect of Citrullus colocynthis Extract on Glycated Hemoglobin Formation (In Vitro) |
| Q92812234 | Effect of Cysteine on Methylglyoxal-Induced Renal Damage in Mesangial Cells |
| Q42434867 | Effect of edaravone in diabetes mellitus-induced nephropathy in rats |
| Q33415190 | Effect of therapeutic plasma exchange on plasma levels of oxidative biomarkers in a patient with thrombotic thrombocytopenic purpura |
| Q52337353 | Effectiveness of arginase inhibitors against experimentally induced stroke. |
| Q92341061 | Effects of exercise training on markers of adipose tissue remodeling in patients with coronary artery disease and type 2 diabetes mellitus: sub study of the randomized controlled EXCADI trial |
| Q51318083 | Effects of ferric citrate supplementation on advanced glycation end products in a rat model of streptozotocin/nicotinamide-induced diabetes. |
| Q46810886 | Effects of insulin combined with idebenone on blood-brain barrier permeability in diabetic rats |
| Q64108807 | Endogenous advanced glycation end products in pancreatic islets after short-term carbohydrate intervention in obese, diabetes-prone mice |
| Q92164576 | Epimedium koreanum Extract and Its Flavonoids Reduced Atherosclerotic Risk via Suppressing Modification of Human HDL |
| Q55104216 | Eucommia ulmoides Ameliorates Glucotoxicity by Suppressing Advanced Glycation End-Products in Diabetic Mice Kidney. |
| Q58761359 | Evaluation of aging, diabetes mellitus, and skin wounds by scanning acoustic microscopy with protease digestion |
| Q35598666 | Expression of the receptor for advanced glycation end products, a target for high mobility group box 1 protein, and its role in chronic recalcitrant rhinosinusitis with nasal polyps |
| Q61796930 | Fangchinoline Ameliorates Diabetic Retinopathy by Inhibiting Receptor for Advanced Glycation End-Products (RAGE)-Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB) Pathway in Streptozotocin (STZ)-Induced Diabetic Rats |
| Q37576023 | Far-infrared protects vascular endothelial cells from advanced glycation end products-induced injury via PLZF-mediated autophagy in diabetic mice. |
| Q38732426 | Ferulic acid prevents methylglyoxal-induced protein glycation, DNA damage, and apoptosis in pancreatic β-cells |
| Q33839188 | Fucaceae: A Source of Bioactive Phlorotannins. |
| Q92242992 | Function of NADPH Oxidases in Diabetic Nephropathy and Development of Nox Inhibitors |
| Q36785519 | Genetic analysis of advanced glycation end products in the DHS MIND study. |
| Q64886019 | Glucose Lowering Effect of Basil Leaves in Diabetic Rats. |
| Q92328208 | Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease |
| Q57495457 | Glycated LDL-C and glycated HDL-C in association with adiposity, blood and atherogenicity indices in metabolic syndrome patients with and without prediabetes |
| Q39430493 | Glycated albumin: a potential biomarker in diabetes. |
| Q92017934 | Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention |
| Q46346267 | Glyoxal toxicity in isolated rat liver mitochondria |
| Q90226833 | Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality |
| Q64937279 | Icariin Inhibits AGE-Induced Injury in PC12 Cells by Directly Targeting Apoptosis Regulator Bax. |
| Q98289099 | In Vitro Antioxidant and Antidiabetic Potentials of Syzygium caryophyllatum L. Alston |
| Q37285455 | In-vivo, non-invasive detection of hyperglycemic states in animal models using mm-wave spectroscopy |
| Q92783034 | Indole-4-carboxaldehyde Isolated from Seaweed, Sargassum thunbergii, Attenuates Methylglyoxal-Induced Hepatic Inflammation |
| Q51284893 | Influence of glyco-oxidation on complexes between fibrin(ogen) and insulin-like growth factor-binding protein-1 in patients with diabetes mellitus type 2. |
| Q38715864 | Inhibition of Methylglyoxal-Induced AGEs/RAGE Expression Contributes to Dermal Protection by N-Acetyl-L-Cysteine |
| Q36366915 | Inhibition of NA(+)/H(+) Exchanger 1 Attenuates Renal Dysfunction Induced by Advanced Glycation End Products in Rats |
| Q46266575 | Inhibitory Effect of Arachis hypogaea (Peanut) and Its Phenolics against Methylglyoxal-Derived Advanced Glycation End Product Toxicity |
| Q35828446 | Inhibitory effect of herbal medicines and their trapping abilities against methylglyoxal-derived advanced glycation end-products |
| Q39290989 | Innovations in Gene and Growth Factor delivery systems for Diabetic Wound Healing |
| Q54328981 | Intrinsic fluorescence and mechanical testing of articular cartilage in human patients with osteoarthritis. |
| Q47397251 | Investigating the preventive effects of baicalin and gallocatechin against glyoxal-induced cystatin aggregation |
| Q37281682 | Involvement of Endoplasmic Reticulum Stress, Autophagy, and Apoptosis in Advanced Glycation End Products-Induced Glomerular Mesangial Cell Injury. |
| Q92730289 | Ion channels and transporters in diabetic kidney disease |
| Q47230788 | Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trial |
| Q37615064 | Is p53 Involved in Tissue-Specific Insulin Resistance Formation? |
| Q35799803 | Isoferulic acid prevents methylglyoxal-induced protein glycation and DNA damage by free radical scavenging activity |
| Q35127451 | Long Term Effect of High Glucose and Phosphate Levels on the OPG/RANK/RANKL/TRAIL System in the Progression of Vascular Calcification in rat Aortic Smooth Muscle Cells |
| Q47303198 | Maillard Proteomics: Opening New Pages |
| Q39293254 | Mangostanaxanthones III and IV: advanced glycation end-product inhibitors from the pericarp of Garcinia mangostana |
| Q88962009 | Mechanisms Underlying Early-Stage Changes in Visual Performance and Retina Function After Experimental Induction of Sustained Dyslipidemia |
| Q55039717 | Metabolic Derangements Contribute to Reduced sRAGE Isoforms in Subjects with Alzheimer's Disease. |
| Q59138235 | Metabolic Effects of Metformin in the Failing Heart |
| Q57795222 | Metabolic syndrome and some of its components in relation to risk of cataract extraction. A prospective cohort study of men |
| Q33918540 | Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds. |
| Q26745606 | Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum? |
| Q91671179 | Modulation of Diabetes Mellitus-Induced Male Rat Reproductive Dysfunction with Micro-Nanoencapsulated Echinacea purpurea Ethanol Extract |
| Q95936565 | Molecular mechanisms of methylglyoxal-induced aortic endothelial dysfunction in human vascular endothelial cells |
| Q64928895 | Monoamine Oxidase-Related Vascular Oxidative Stress in Diseases Associated with Inflammatory Burden. |
| Q46726001 | Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes |
| Q58702059 | Multifaceted Interweaving Between Extracellular Matrix, Insulin Resistance, and Skeletal Muscle |
| Q59133666 | Multimodal imaging of the receptor for advanced glycation end-products with molecularly targeted nanoparticles |
| Q64914993 | Multiple Glycation Sites in Blood Plasma Proteins as an Integrated Biomarker of Type 2 Diabetes Mellitus. |
| Q47094741 | NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes. |
| Q61805142 | Neurons and Microglia; A Sickly-Sweet Duo in Diabetic Pain Neuropathy |
| Q26746285 | Neuropathy and Diabetic Foot Syndrome |
| Q59329759 | Neuroprotective effects of vitamin D on high fat diet- and palmitic acid-induced enteric neuronal loss in mice |
| Q90582750 | Obesity and type-2 diabetes as inducers of premature cellular senescence and ageing |
| Q59800367 | Of mice and men: models and mechanisms of diabetic cardiomyopathy |
| Q45711807 | Ophthalmic manifestations of endocrine disorders-endocrinology and the eye. |
| Q50232896 | Oral Magnesium Treatment Reduces Anemia and Levels of Inflammatory Markers in Experimental Diabetes |
| Q38473579 | Oxidation as an important factor of protein damage: Implications for Maillard reaction. |
| Q51055607 | PERK and XBP1 differentially regulate CXCL10 and CCL2 production. |
| Q98288728 | Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: the Receptor for Advanced Glycation End Products (RAGE) |
| Q50655623 | Peripheral Levels of AGEs and Astrocyte Alterations in the Hippocampus of STZ-Diabetic Rats. |
| Q91949654 | Persistent organic pollutants (POPs) increase rage signaling to promote downstream cardiovascular remodeling |
| Q53771352 | Phenolics from Garcinia mangostana Inhibit Advanced Glycation Endproducts Formation: Effect on Amadori Products, Cross-Linked Structures and Protein Thiols. |
| Q39064669 | Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2. |
| Q64231660 | Potential Antiglycation and Hypoglycaemic Effects of M. Roem. and Lam. Thell. Crude Extracts in Differentiated C2C12 Cells |
| Q93087981 | Potential Diagnostic Hemorheological Indexes for Chronic Kidney Disease in Patients With Type 2 Diabetes |
| Q55190271 | Prevalence of musculoskeletal pain in association with serum 25-hydroxyvitamin D concentrations in patients with type 2 diabetes mellitus. |
| Q51330021 | Prevention and treatment of diabetic foot ulcers. |
| Q26751110 | Prevention of non-enzymatic glycosylation (glycation): Implication in the treatment of diabetic complication |
| Q47340371 | Probing Protein Glycation by Chromatography and Mass Spectrometry: Analysis of Glycation Adducts. |
| Q41680141 | Protective activity of gallic acid against glyoxal -induced renal fibrosis in experimental rats |
| Q37633289 | Protective effect of mangiferin on myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats: role of AGE-RAGE/MAPK pathways |
| Q64251542 | Protective effect of myricetin derivatives from against hydrogen peroxide-induced stress in ARPE-19 cells |
| Q37734095 | Protein Mediated Oxidative Stress in Patients with Diabetes and its Associated Neuropathy: Correlation with Protein Carbonylation and Disease Activity Markers |
| Q47393105 | Protein Repair from Glycation by Glyoxals by the DJ-1 Family Maillard Deglycases |
| Q36563327 | Protein carbamylation is a hallmark of aging |
| Q38447792 | Protein pathways working in human follicular fluid: the future for tailored IVF? |
| Q38680453 | Protocatechuic Acid, a Phenolic from Sansevieria roxburghiana Leaves, Suppresses Diabetic Cardiomyopathy via Stimulating Glucose Metabolism, Ameliorating Oxidative Stress, and Inhibiting Inflammation |
| Q88487528 | Reactive Oxygen Species in Metabolic and Inflammatory Signaling |
| Q89634122 | Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases |
| Q42270747 | Relationship between hemoglobin glycation index and extent of coronary heart disease in individuals with type 2 diabetes mellitus: a cross-sectional study |
| Q37376832 | Relationship of cytokines and AGE products in diabetic and non-diabetic patients with cataract |
| Q42876331 | Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes |
| Q99561828 | Retinal Physiology and Circulation: Effect of Diabetes |
| Q89482685 | Role of AGEs in the progression and regression of atherosclerotic plaques |
| Q58577346 | Role of advanced glycation end products in mobility and considerations in possible dietary and nutritional intervention strategies |
| Q36529128 | Role of the RAGE Axis during the Immune Response after Severe Trauma: A Prospective Pilot Study |
| Q60061927 | Sensory neuronal sensitisation occurs through HMGB-1-RAGE and TRPV1 in high-glucose conditions |
| Q89733317 | Skeletal Muscle Reflex-Induced Sympathetic Dysregulation and Sensitization of Muscle Afferents in Type 1 Diabetic Rats |
| Q51622193 | Study on the interactions of sulfonylurea antidiabetic drugs with normal and glycated human serum albumin by capillary electrophoresis-frontal analysis. |
| Q47100384 | Superoxide Scavenging and Antiglycation Activity of Rhinacanthins-rich Extract Obtained from the Leaves of Rhinacanthus nasutus. |
| Q89560440 | Supplementation with Korean Red Ginseng Improves Current Perception Threshold in Korean Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Q57688718 | T cell activation and cardiovascular risk in type 2 diabetes mellitus: a protocol for a systematic review and meta-analysis |
| Q33783975 | TRB3 mediates advanced glycation end product-induced apoptosis of pancreatic β-cells through the protein kinase C β pathway |
| Q92246496 | Targeting MMP-9 in Diabetic Foot Ulcers |
| Q47094524 | The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases |
| Q42318306 | The Antidiabetic Activity of Nigella sativa and Propolis on Streptozotocin-Induced Diabetes and Diabetic Nephropathy in Male Rats. |
| Q92178385 | The Antiglycoxidative Ability of Selected Phenolic Compounds-An In Vitro Study |
| Q90451562 | The Diethylcarbamazine Delays and Decreases the NETosis of Polymorphonuclear Cells of Humans with DM Type 2 |
| Q47642022 | The Effects of Coenzyme Q10 Supplementation on Glucose Metabolism, Lipid Profiles, Inflammation, and Oxidative Stress in Patients With Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial |
| Q98465714 | The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System |
| Q93078010 | The Experiences of People Living with Peripheral Neuropathy in Kuwait-A Process Map of the Patient Journey |
| Q55416114 | The Role of Advanced Glycation End Products in Diabetic Vascular Complications. |
| Q59329530 | The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review |
| Q100559700 | The structural role of osteocalcin in bone biomechanics and its alteration in Type-2 Diabetes |
| Q92343798 | Therapeutic Potential of Lespedeza bicolor to Prevent Methylglyoxal-Induced Glucotoxicity in Familiar Diabetic Nephropathy |
| Q90105874 | Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment |
| Q89900383 | UHPLC-QTOF-MS/MS based phytochemical characterization and anti-hyperglycemic prospective of hydro-ethanolic leaf extract of Butea monosperma |
| Q41833272 | Update on Mechanisms of Renal Tubule Injury Caused by Advanced Glycation End Products |
| Q97681402 | Urolithin A suppresses high glucose-induced neuronal amyloidogenesis by modulating TGM2-dependent ER-mitochondria contacts and calcium homeostasis |
| Q94665718 | Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin |
| Q57491273 | Use of Raman spectroscopy to screen diabetes mellitus with machine learning tools |
| Q48338722 | Vanillin Affects Amyloid Aggregation and Non-Enzymatic Glycation in Human Insulin. |
| Q90426020 | Vitamin D3 regulates apoptosis and proliferation in the testis of D-galactose-induced aged rat model |
| Q87168542 | [Neuropathy and diabetic foot ulcers] |
| Q35884279 | α-glucosidase and glycation inhibitory effects of costus speciosus leaves |
Search more.